Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature

The cost effectiveness of treatments that have changed the “natural history” of a chronic progressive disease needs to be evaluated over the long term. Disease-modifying antirheumatic drugs (DMARDs) are the standard treatment of rheumatoid arthritis (RA) and should be started as early as possible. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Benucci, Maurizio, Saviola, Gianantonio, Manfredi, Mariangela, Sarzi-Puttini, Piercarlo, Atzeni, Fabiola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228304/
https://www.ncbi.nlm.nih.gov/pubmed/22162693
http://dx.doi.org/10.1155/2011/845496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228304/
https://www.ncbi.nlm.nih.gov/pubmed/22162693
http://dx.doi.org/10.1155/2011/845496

Ejemplares similares